微信公众号
证券之星APP
| 报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | 57.37% | -36.87% | -4.45% | 62/160 | 22.89% | 迪哲医药 | 97.73% | 行业排名> |
| 2024-06-30 | 60.04% | -35.64% | 2.38% | 53/160 | 33.26% | 百利天恒 | 97.99% | 行业排名> |
| 2024-03-31 | 58.64% | -38.4% | -30.79% | 53/160 | 51.37% | 百利天恒 | 98.92% | 行业排名> |
| 2023-12-31 | 84.73% | -1.24% | -6.77% | 12/160 | 51.37% | 迈威生物 | 98.93% | 行业排名> |
| 2023-09-30 | 90.88% | 6.74% | -2.58% | 7/160 | 32.75% | 迈威生物 | 99.59% | 行业排名> |
| 2023-06-30 | 93.28% | 9.72% | -2.02% | 3/160 | 38.61% | 迈威生物 | 99.8% | 行业排名> |
| 2023-03-31 | 95.2% | 17.18% | 10.98% | 3/160 | 52.91% | 迈威生物 | 99.46% | 行业排名> |
| 2022-12-31 | 85.79% | -1.53% | 0.77% | 13/160 | 53.57% | 迈威生物 | 99.75% | 行业排名> |
| 2022-09-30 | 85.14% | -3.8% | 0.14% | 13/160 | 6.69% | 迈威生物 | 99.67% | 行业排名> |
| 2022-06-30 | 85.02% | -5.68% | 4.64% | 13/160 | 21.79% | 迈威生物 | 99.44% | 行业排名> |
| 2022-03-31 | 81.25% | -12.59% | -6.75% | 20/160 | 54.47% | 迈威生物 | 98.57% | 行业排名> |
| 2021-12-31 | 87.12% | -3.12% | -1.56% | 14/160 | 55.07% | 首药控股 | 99.93% | 行业排名> |
| 2021-09-30 | 88.5% | -1.79% | -1.81% | 9/160 | 47.01% | 艾力斯 | 99.41% | 行业排名> |
| 2021-06-30 | 90.13% | 0.12% | -3.03% | 9/160 | 47.45% | 艾力斯 | 98.7% | 行业排名> |
| 2021-03-31 | 92.95% | 4.45% | 3.36% | 5/160 | 54.21% | 艾力斯 | 99.4% | 行业排名> |
| 2020-12-31 | 89.93% | 1.49% | -0.2% | 9/160 | -143.08% | 首药控股 | 99.94% | 行业排名> |
| 2020-09-30 | 90.11% | 2% | 0.1% | 7/160 | 56.57% | 泽璟制药 | 99.96% | 行业排名> |
| 2020-06-30 | 90.02% | 4% | 1.16% | 6/160 | 54.32% | 微芯生物 | 95.14% | 行业排名> |
| 2020-03-31 | 88.99% | 2% | 0.42% | 5/160 | 55.5% | 多瑞医药 | 95.59% | 行业排名> |
| 2019-12-31 | 88.61% | 3.54% | 2.38% | 6/160 | -1204.25% | 微芯生物 | 95.81% | 行业排名> |
| 2019-06-30 | 86.56% | 2% | 1.14% | 8/160 | 55.36% | 微芯生物 | 96.09% | 行业排名> |
| 2018-12-31 | 85.58% | 20.31% | 20.31% | 13/160 | -205.91% | 微芯生物 | 96.11% | 行业排名> |
| 2017-12-31 | 71.13% | 17.92% | 17.92% | 25/160 | 52.58% | 微芯生物 | 95.5% | 行业排名> |
| 2016-12-31 | 60.32% | 2% | 2% | 33/160 | 48.44% | 微芯生物 | 96.27% | 行业排名> |